Summit Securities Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-467,500
Closed -$107M 998
2023
Q4
$107M Buy
467,500
+4,200
+0.9% +$903K 9.65% 1
2023
Q3
$98.3M Sell
463,300
-30,500
-6% -$6.09M 10.11% 2
2023
Q2
$95M Buy
493,800
+461,300
+1,419% +$91.6M 12.39% 1
2023
Q1
$6.58M Buy
32,500
+20,000
+160% +$3.21M 0.54% 35
2022
Q4
$1.61M Sell
12,500
-50,000
-80% -$6.45M 0.06% 137
2022
Q3
$8.55M Buy
62,500
+61,800
+8,829% +$10.1M 0.64% 34
2022
Q2
$124K Buy
+700
New +$101K 0.02% 379

Summit Securities Group's SGEN Position: Q4 2023 in Review

Summit Securities Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 21 shares — an estimated $4.51K sold.

Summit Securities Group first reported a position in SGEN in Q1 2022 and held it in 4 quarters. The position peaked at $142K in Q2 2022. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Summit Securities Group reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Summit Securities Group sold 21 Seagen Inc. Common Stock shares in Q4 2023, an estimated $4.51K.
  • Summit Securities Group first reported a position in Seagen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Summit Securities Group's Seagen Inc. Common Stock position peaked at $142K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Summit Securities Group's 13F filing for Q4 2023, filed 14 Feb 2024.